Stocks Health care RANI
NASDAQ · Health careRani Therapeutics Holdings, Inc. (RANI)
Rani Therapeutics Holdings, Inc. brought in $4.9M of revenue over the twelve months to June 30, 2026, up 306.4% from a year earlier. It posted a net loss of $30.1M. In fiscal 2025 capital spending exceeded operating cash flow by $18.8M. At June 30, 2026 it held $4.9M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 13, 2026.
What Rani Therapeutics Holdings, Inc. does
Rani Therapeutics Holdings, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker RANI.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $1.6M | -$29.7M | -$0.45 | -$18.8M |
| 2024 | $1M | -$30M | -$1.05 | -$35.8M |
| 2023 | $0 | -$34M | -$1.33 | -$52.5M |
| 2022 | $0 | -$30.6M | -$1.28 | -$48.1M |
| 2021 | $2.7M | -$8.3M | -$0.43 | -$32.8M |
| 2021 | $462K | -$16.7M | n/a | -$16.2M |
Latest SEC filings
What Rani Therapeutics Holdings, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- August 14, 2026Passive stake changed SCHEDULE 13G/A
- August 13, 2026Quarterly report 10-Q · period to June 30, 2026
- August 13, 2026
- August 4, 2026
- July 31, 2026Passive stake changed SCHEDULE 13G/A
- July 15, 2026
- June 30, 2026
- May 29, 2026
- May 28, 2026Activist stake changed SCHEDULE 13D/A
- May 27, 2026Other event 8-K
Questions about RANI
What does Rani Therapeutics Holdings, Inc. do?
Rani Therapeutics Holdings, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker RANI.
Is Rani Therapeutics Holdings, Inc. profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $30.1M on revenue of $4.9M.
How much revenue does Rani Therapeutics Holdings, Inc. make?
Over the twelve months to June 30, 2026 Rani Therapeutics Holdings, Inc. reported revenue of $4.9M. That is 306.4% more than a year earlier.
When did Rani Therapeutics Holdings, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 13, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the passive stake changed from August 14, 2026.
Similar companies
Follow RANI
Get an email when Rani Therapeutics Holdings, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Follow RANI: get an email when it filesWhere the numbers come from
Financial figures are the values Rani Therapeutics Holdings, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.